Drug Discovery · Boston, MA · Founded 2019 · Privately Held (backing)
Operator of a biotech company intended to develop a genomic medicine in vivo approach to engineer any or all blood and immune cells to cure diseases. Ensoma is based in Boston, MA and was founded in 2019. Its last reported valuation was $280 million in May 2023. It has raised $258 million across 3 recorded rounds; the latest was a $53 million Series B1 in Sep 2025.
Last reported valuation
$280.0M
Oct 2026
Priced at
—
Total raised
$258.0M
Last round
Later Stage VC (Series B1)
Sep 2025
Team — not yet on record
No current team members for Ensoma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Ensoma with a free account
·The complete investor list: 21 names
·Watch Ensoma: the Monday email on marks, rounds and moves
